Format
Sort by
Items per page

Send to

Choose Destination

Best matches for pharmacogenetics review:

Search results

Items: 1 to 20 of 5787

1.

Live or let die: Neuroprotective and anti-cancer effects of nutraceutical antioxidants.

Mao XY, Jin MZ, Chen JF, Zhou HH, Jin WL.

Pharmacol Ther. 2017 Oct 18. pii: S0163-7258(17)30262-0. doi: 10.1016/j.pharmthera.2017.10.012. [Epub ahead of print] Review.

PMID:
29055715
2.

Individual variability in clinical effect and tolerability of opioid analgesics - Importance of drug interactions and pharmacogenetics.

Solhaug V, Molden E.

Scand J Pain. 2017 Oct 17;17:193-200. doi: 10.1016/j.sjpain.2017.09.009. [Epub ahead of print] Review.

PMID:
29054049
3.

Pharmacogenetics: a general review on progress to date.

Daly AK.

Br Med Bull. 2017 Oct 11:1-15. doi: 10.1093/bmb/ldx035. [Epub ahead of print]

PMID:
29040422
4.

eIF3a: A new anticancer drug target in the eIF family.

Yin JY, Zhang JT, Zhang W, Zhou HH, Liu ZQ.

Cancer Lett. 2017 Oct 12. pii: S0304-3835(17)30627-4. doi: 10.1016/j.canlet.2017.09.055. [Epub ahead of print]

PMID:
29031564
5.

Pharmacoepigenetics and Toxicoepigenetics: Novel Mechanistic Insights and Therapeutic Opportunities.

Lauschke VM, Barragan I, Ingelman-Sundberg M.

Annu Rev Pharmacol Toxicol. 2017 Oct 13. doi: 10.1146/annurev-pharmtox-010617-053021. [Epub ahead of print]

PMID:
29029592
6.

Application of Microphysiological Systems to Enhance Safety Assessment in Drug Discovery.

Ewart L, Dehne EM, Fabre K, Gibbs S, Hickman J, Hornberg E, Ingelman-Sundberg M, Jang KJ, Jones DR, Lauschke VM, Marx U, Mettetal JT, Pointon A, Williams D, Zimmermann WH, Newham P.

Annu Rev Pharmacol Toxicol. 2017 Oct 13. doi: 10.1146/annurev-pharmtox-010617-052722. [Epub ahead of print]

PMID:
29029591
7.

Comparison of the Guidelines of the Clinical Pharmacogenetics Implementation Consortium and the Dutch Pharmacogenetics Working Group.

Bank PC, Caudle KE, Swen JJ, Gammal RS, Whirl-Carrillo M, Klein TE, Relling MV, Guchelaar HJ.

Clin Pharmacol Ther. 2017 Jun 9. doi: 10.1002/cpt.762. [Epub ahead of print] Review.

PMID:
28994452
8.

Pharmacogenetic considerations for HIV treatment in different ethnicities: an update.

Neary M, Owen A.

Expert Opin Drug Metab Toxicol. 2017 Oct 16:1-13. doi: 10.1080/17425255.2017.1391214. [Epub ahead of print]

PMID:
28994310
9.

DPP-4 inhibitors and heart failure: a potential role for pharmacogenomics.

Krittanawong C, Xanthopoulos A, Kitai T, Branis N, Zhang H, Kukin M.

Heart Fail Rev. 2017 Oct 6. doi: 10.1007/s10741-017-9655-y. [Epub ahead of print] Review.

PMID:
28986727
10.

AGXT2: An unnegligible aminotransferase in cardiovascular and urinary systems.

Hu XL, Li MP, Song PY, Tang J, Chen XP.

J Mol Cell Cardiol. 2017 Dec;113:33-38. doi: 10.1016/j.yjmcc.2017.09.010. Epub 2017 Sep 29. Review.

PMID:
28970090
11.

Dopamine, the antipsychotic molecule: A perspective on mechanisms underlying antipsychotic response variability.

Amato D, Vernon AC, Papaleo F.

Neurosci Biobehav Rev. 2017 Sep 29. pii: S0149-7634(17)30046-5. doi: 10.1016/j.neubiorev.2017.09.027. [Epub ahead of print] Review.

PMID:
28970021
12.

Genetic signatures in ischemic stroke: Focus on aspirin resistance.

Munshi A, Vasudeva K, Chaurasia P, Singh S.

CNS Neurol Disord Drug Targets. 2017 Oct 2. doi: 10.2174/1871527316666171002115633. [Epub ahead of print]

PMID:
28969559
13.

Cost effectiveness analysis of HLA-B*58:01 genotyping prior to initiation of allopurinol for gout.

Plumpton CO, Alfirevic A, Pirmohamed M, Hughes DA.

Rheumatology (Oxford). 2017 Oct 1;56(10):1729-1739. doi: 10.1093/rheumatology/kex253. Review.

PMID:
28957559
14.

Pharmacogenetics of Lipid-Lowering Agents: an Update Review on Genotype-Dependent Effects of HDL-Targetingand Statin Therapies.

Messas N, Dubé MP, Tardif JC.

Curr Atheroscler Rep. 2017 Sep 25;19(11):43. doi: 10.1007/s11883-017-0679-5. Review.

PMID:
28944433
15.

Metastasis-associated in colon cancer 1: A promising biomarker for the metastasis and prognosis of colorectal cancer.

Li H, Chen YX, Wen JG, Zhou HH.

Oncol Lett. 2017 Oct;14(4):3899-3908. doi: 10.3892/ol.2017.6670. Epub 2017 Jul 26.

16.
17.

Pharmacogenetics and Pharmacogenomics in Moderate-to-Severe Psoriasis.

Ovejero-Benito MC, Muñoz-Aceituno E, Reolid A, Saiz-Rodríguez M, Abad-Santos F, Daudén E.

Am J Clin Dermatol. 2017 Sep 18. doi: 10.1007/s40257-017-0322-9. [Epub ahead of print] Review.

PMID:
28921458
18.

MECHANISMS IN ENDOCRINOLOGY: Clinical and pharmacogenetic aspects of the growth hormone receptor polymorphism.

Boguszewski CL, Barbosa EJL, Svensson PA, Johannsson G, Glad CAM.

Eur J Endocrinol. 2017 Dec;177(6):R309-R321. doi: 10.1530/EJE-17-0549. Epub 2017 Sep 13. Review.

19.

Pharmacogenetics of opioid analgesics in dogs.

Kongara K.

J Vet Pharmacol Ther. 2017 Sep 11. doi: 10.1111/jvp.12452. [Epub ahead of print] Review.

PMID:
28892154
20.

Germline genetic variants with implications for disease risk and therapeutic outcomes.

Pasternak AL, Ward KM, Luzum JA, Ellingrod VL, Hertz DL.

Physiol Genomics. 2017 Oct 1;49(10):567-581. doi: 10.1152/physiolgenomics.00035.2017. Epub 2017 Sep 8. Review.

PMID:
28887371

Supplemental Content

Loading ...
Support Center